Berthon, Antonin https://orcid.org/0000-0002-0200-0931
Wernisch, Lorenz
Stoukidi, Myrta
Thornton, Michael
Tessier-Lariviere, Olivier
Fortier-Poisson, Pascal
Mamen, Jorin
Pinkney, Max
Lee, Susannah
Sarkans, Elvijs
Annecchino, Luca
Appleton, Ben
Garsed, Philip
Patterson, Bret
Gonshaw, Samuel
Jakopec, Matjaz
Shunmugam, Sudhakaran
Edwards, Tristan
Tukiainen, Aleksi
Jennings, Joel
Lajoie, Guillaume
Hewage, Emil
Armitage, Oliver
Funding for this research was provided by:
National Institutes of Health (OT2OD030536)
Article History
Received: 27 February 2024
Accepted: 17 May 2024
First Online: 17 June 2024
Declarations
:
: Experiments were conducted under the approval of the local Institute of Animal Care and Use Committee, and approved in accordance with the animal use policy of BIOS Health Ltd.
: Not applicable.
: All authors, except AT, are (or were at the time of their contribution) employees of BIOS Health Ltd., and declare that BIOS Health has filed US and international patent applications relating to a system, apparatus and method for utilising neural biomarker response in clinical decision-making. The concepts of this work is contained in the UK Patent GB 2214547.8. AT declares a consulting role with BIOS Health at the time the research was conducted. GL holds a position at the Université de Montréal and Mila-Quebec AI Institute and declares receiving funding from BIOS Health Ltd topics related to the present publication, but that was not in place at the time of the development of this manuscript.